{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:42:46Z","timestamp":1772491366329,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,27]]},"DOI":"10.7759\/cureus.14709","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T08:54:54Z","timestamp":1619513694000},"source":"Crossref","is-referenced-by-count":6,"title":["New Strategies in Neurogenic Heterotopic Ossification"],"prefix":"10.7759","author":[{"given":"Margarita-Michaela","family":"Ampadiotaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios S","family":"Evangelopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Pallis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Vlachos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Vlamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Eleftheria","family":"Evangelopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10172","article-title":"Heterotopic ossification: a comprehensive review","volume":"3","author":"Meyers C","year":"2019","unstructured":"Meyers C, Lisiecki J, Miller S, et al.. Heterotopic ossification: a comprehensive review. JBMR Plus. 2019, 3:e10172. 10.1002\/jbm4.10172","journal-title":"JBMR Plus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.08.025","article-title":"Heterotopic ossification: mechanistic insights and clinical challenges","volume":"109","author":"Xu R","year":"2018","unstructured":"Xu R, Hu J, Zhou X, Yang Y. Heterotopic ossification: mechanistic insights and clinical challenges. Bone. 2018, 109:134-42. 10.1016\/j.bone.2017.08.025","journal-title":"Bone"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/path.4519","article-title":"Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle","volume":"236","author":"Gen\u00eat F","year":"2015","unstructured":"Gen\u00eat F, Kulina I, Vaquette C, et al.. Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle. J Pathol. 2015, 236:229-40. 10.1002\/path.4519","journal-title":"J Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.04.014","article-title":"Conserved signaling pathways underlying heterotopic ossification","volume":"109","author":"Kan C","year":"2018","unstructured":"Kan C, Chen L, Hu Y, et al.. Conserved signaling pathways underlying heterotopic ossification. Bone. 2018, 109:43-8. 10.1016\/j.bone.2017.04.014","journal-title":"Bone"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rehab.2018.09.004","article-title":"Orthopaedic surgery for patients with central nervous system lesions: Concepts and techniques","volume":"62","author":"Gen\u00eat F","year":"2019","unstructured":"Gen\u00eat F, Denormandie P, Keenan MA. Orthopaedic surgery for patients with central nervous system lesions: Concepts and techniques. Ann Phys Rehabil Med. 2019, 62:225-33. 10.1016\/j.rehab.2018.09.004","journal-title":"Ann Phys Rehabil Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41394-019-0216-6","article-title":"Incidence and characteristics of heterotopic ossification after spinal cord injury: a single institution study in India","volume":"5","author":"Rawat N","year":"2019","unstructured":"Rawat N, Chugh S, Zachariah K, Ghosh S. Incidence and characteristics of heterotopic ossification after spinal cord injury: a single institution study in India. Spinal Cord Ser Cases. 2019, 5:72. 10.1038\/s41394-019-0216-6","journal-title":"Spinal Cord Ser Cases"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0b013e31817c16d6","article-title":"Secondary health complications in an aging Canadian spinal cord injury sample","volume":"87","author":"Hitzig SL","year":"2008","unstructured":"Hitzig SL, Tonack M, Campbell KA, McGillivray CF, Boschen KA, Richards K, Craven BC. Secondary health complications in an aging Canadian spinal cord injury sample. Am J Phys Med Rehabil. 2008, 87:545-55. 10.1097\/PHM.0b013e31817c16d6","journal-title":"Am J Phys Med Rehabil"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1302\/2046-3758.23.2000152","article-title":"Heterotopic ossification after central nervous system trauma: a current review","volume":"2","author":"Sullivan MP","year":"2013","unstructured":"Sullivan MP, Torres SJ, Mehta S, Ahn J. Heterotopic ossification after central nervous system trauma: a current review. Bone Joint Res. 2013, 2:51-7. 10.1302\/2046-3758.23.2000152","journal-title":"Bone Joint Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00068-013-0353-8","article-title":"Autonomic dysreflexia: a possible trigger for the development of heterotopic ossifications after traumatic spinal cord injury?: a clinical longitudinal study","volume":"40","author":"Putz C","year":"2014","unstructured":"Putz C, Helbig L, Gerner HJ, Zimmermann-Stenzel M, Akbar M. Autonomic dysreflexia: a possible trigger for the development of heterotopic ossifications after traumatic spinal cord injury?: a clinical longitudinal study. Eur J Trauma Emerg Surg. 2014, 40:721-6. 10.1007\/s00068-013-0353-8","journal-title":"Eur J Trauma Emerg Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-200911000-00003","article-title":"Heterotopic ossification following traumatic brain injury and spinal cord injury","volume":"17","author":"Cipriano CA","year":"2009","unstructured":"Cipriano CA, Pill SG, Keenan MA. Heterotopic ossification following traumatic brain injury and spinal cord injury. J Am Acad Orthop Surg. 2009, 17:689-97. 10.5435\/00124635-200911000-00003","journal-title":"J Am Acad Orthop Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-014-4076-x","article-title":"Classifications in brief: Brooker classification of heterotopic ossification after total hip arthroplasty","volume":"473","author":"Hug KT","year":"2015","unstructured":"Hug KT, Alton TB, Gee AO. Classifications in brief: Brooker classification of heterotopic ossification after total hip arthroplasty. Clin Orthop Relat Res. 2015, 473:2154-7. 10.1007\/s11999-014-4076-x","journal-title":"Clin Orthop Relat Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10195-012-0193-z","article-title":"A classification method for neurogenic heterotopic ossification of the hip","volume":"13","author":"Mavrogenis AF","year":"2012","unstructured":"Mavrogenis AF, Guerra G, Staals EL, Bianchi G, Ruggieri P. A classification method for neurogenic heterotopic ossification of the hip. J Orthop Traumatol. 2012, 13:69-78. 10.1007\/s10195-012-0193-z","journal-title":"J Orthop Traumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.06.014","article-title":"Targeted stimulation of retinoic acid receptor-\u03b3 mitigates the formation of heterotopic ossification in an established blast-related traumatic injury model","volume":"90","author":"Pavey GJ","year":"2016","unstructured":"Pavey GJ, Qureshi AT, Tomasino AM, et al.. Targeted stimulation of retinoic acid receptor-\u03b3 mitigates the formation of heterotopic ossification in an established blast-related traumatic injury model. Bone. 2016, 90:159-67. 10.1016\/j.bone.2016.06.014","journal-title":"Bone"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2016.93","article-title":"The sensitivity of ultrasound screening examination in detecting heterotopic ossification following spinal cord injury","volume":"55","author":"Rosteius T","year":"2017","unstructured":"Rosteius T, Suero EM, Grasm\u00fccke D, et al.. The sensitivity of ultrasound screening examination in detecting heterotopic ossification following spinal cord injury. Spinal Cord. 2017, 55:71-3. 10.1038\/sc.2016.93","journal-title":"Spinal Cord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/cc5083","article-title":"Heterotopic ossification of the knee joint in intensive care unit patients: early diagnosis with magnetic resonance imaging","volume":"10","author":"Argyropoulou MI","year":"2006","unstructured":"Argyropoulou MI, Kostandi E, Kosta P, et al.. Heterotopic ossification of the knee joint in intensive care unit patients: early diagnosis with magnetic resonance imaging. Crit Care. 2006, 10:R152. 10.1186\/cc5083","journal-title":"Crit Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/03008207.2015.1013190","article-title":"Pilot study for detection of early changes in tissue associated with heterotopic ossification: moving toward clinical use of Raman spectroscopy","volume":"56","author":"Harris M","year":"2015","unstructured":"Harris M, Cilwa K, Elster EA, Potter BK, Forsberg JA, Crane NJ. Pilot study for detection of early changes in tissue associated with heterotopic ossification: moving toward clinical use of Raman spectroscopy. Connect Tissue Res. 2015, 56:144-52. 10.3109\/03008207.2015.1013190","journal-title":"Connect Tissue Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00282","article-title":"Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms","volume":"10","author":"Alizadeh A","year":"2019","unstructured":"Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front Neurol. 2019, 10:282. 10.3389\/fneur.2019.00282","journal-title":"Front Neurol"},{"key":"ref18","article-title":"Sodium selenate treatment mitigates reduction of bone volume following traumatic brain injury in rats","volume":"16","author":"Brady RD","year":"2016","unstructured":"Brady RD, Grills BL, Romano T, Wark JD, O'Brien TJ, Shultz SR, McDonald SJ. Sodium selenate treatment mitigates reduction of bone volume following traumatic brain injury in rats. J Musculoskelet Neuronal Interact. 2016, 16:369-76.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.01.029","article-title":"Stem cells and heterotopic ossification: Lessons from animal models","volume":"109","author":"Lees-Shepard JB","year":"2018","unstructured":"Lees-Shepard JB, Goldhamer DJ. Stem cells and heterotopic ossification: Lessons from animal models. Bone. 2018, 109:178-86. 10.1016\/j.bone.2018.01.029","journal-title":"Bone"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3304","article-title":"Depletion of mast cells and macrophages impairs heterotopic ossification in an Acvr1R206H mouse model of fibrodysplasia ossificans progressiva","volume":"33","author":"Convente MR","year":"2018","unstructured":"Convente MR, Chakkalakal SA, Yang E, et al.. Depletion of mast cells and macrophages impairs heterotopic ossification in an Acvr1R206H mouse model of fibrodysplasia ossificans progressiva. J Bone Miner Res. 2018, 33:269-82. 10.1002\/jbmr.3304","journal-title":"J Bone Miner Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2018.03.007","article-title":"Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities","volume":"40","author":"Pacifici M","year":"2018","unstructured":"Pacifici M. Acquired and congenital forms of heterotopic ossification: new pathogenic insights and therapeutic opportunities. Curr Opin Pharmacol. 2018, 40:51-8. 10.1016\/j.coph.2018.03.007","journal-title":"Curr Opin Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156253","article-title":"Characterization of cells isolated from genetic and trauma-induced heterotopic ossification","volume":"11","author":"Agarwal S","year":"2016","unstructured":"Agarwal S, Drake J, Qureshi AT, et al.. Characterization of cells isolated from genetic and trauma-induced heterotopic ossification. PLoS One. 2016, 11:e0156253. 10.1371\/journal.pone.0156253","journal-title":"PLoS One"},{"key":"ref23","article-title":"Comparative study of serum levels of BMP-2 and heterotopic ossification in traumatic brain injury and fractures patients","volume":"24","author":"Wang YK","year":"2011","unstructured":"Wang YK, Sun WF, Liu XG, Deng J, Yan BE, Jiang WY, Lin XB. Comparative study of serum levels of BMP-2 and heterotopic ossification in traumatic brain injury and fractures patients. Zhongguo Gu Shang. 2011, 24:399-403.","journal-title":"Zhongguo Gu Shang"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2013.09.029","article-title":"Molecular mechanisms of heterotopic ossification","volume":"39","author":"Reichel LM","year":"2014","unstructured":"Reichel LM, Salisbury E, Moustoukas MJ, Davis AR, Olmsted-Davis E. Molecular mechanisms of heterotopic ossification. J Hand Surg Am. 2014, 39:563-6. 10.1016\/j.jhsa.2013.09.029","journal-title":"J Hand Surg Am"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2844","article-title":"Differential regulation of human bone marrow mesenchymal stromal cell chondrogenesis by hypoxia inducible factor-1\u03b1 hydroxylase inhibitors","volume":"36","author":"Taheem DK","year":"2018","unstructured":"Taheem DK, Foyt DA, Loaiza S, et al.. Differential regulation of human bone marrow mesenchymal stromal cell chondrogenesis by hypoxia inducible factor-1\u03b1 hydroxylase inhibitors. Stem Cells. 2018, 36:1380-92. 10.1002\/stem.2844","journal-title":"Stem Cells"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2848","article-title":"Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling","volume":"31","author":"Wang H","year":"2016","unstructured":"Wang H, Lindborg C, Lounev V, et al.. Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling. J Bone Miner Res. 2016, 31:1652-65. 10.1002\/jbmr.2848","journal-title":"J Bone Miner Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-0509-1","article-title":"The hypoxic microenvironment: a driving force for heterotopic ossification progression","volume":"18","author":"Huang Y","year":"2020","unstructured":"Huang Y, Wang X, Lin H. The hypoxic microenvironment: a driving force for heterotopic ossification progression. Cell Commun Signal. 2020, 18:20. 10.1186\/s12964-020-0509-1","journal-title":"Cell Commun Signal"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1515397113","article-title":"Inhibition of Hif1\u03b1 prevents both trauma-induced and genetic heterotopic ossification","volume":"113","author":"Agarwal S","year":"2016","unstructured":"Agarwal S, Loder S, Brownley C, et al.. Inhibition of Hif1\u03b1 prevents both trauma-induced and genetic heterotopic ossification. Proc Natl Acad Sci U S A. 2016, 113:E338-47. 10.1073\/pnas.1515397113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI93521","article-title":"Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva","volume":"127","author":"Hino K","year":"2017","unstructured":"Hino K, Horigome K, Nishio M, et al.. Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva. J Clin Invest. 2017, 127:3339-52. 10.1172\/JCI93521","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13025","article-title":"Challenges of heterotopic ossification-Molecular background and current treatment strategies","volume":"45","author":"\u0141\u0119gosz P","year":"2018","unstructured":"\u0141\u0119gosz P, Drela K, Pulik \u0141, Sarzy\u0144ska S, Ma\u0142dyk P. Challenges of heterotopic ossification-Molecular background and current treatment strategies. Clin Exp Pharmacol Physiol. 2018, 45:1229-35. 10.1111\/1440-1681.13025","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41393-018-0199-3","article-title":"Use of nonsteroidal anti-inflammatory drugs to prevent heterotopic ossification after spinal cord injury: a retrospective chart review","volume":"57","author":"Zakrasek EC","year":"2019","unstructured":"Zakrasek EC, Yurkiewicz SM, Dirlikov B, Pence BT, Crew JD. Use of nonsteroidal anti-inflammatory drugs to prevent heterotopic ossification after spinal cord injury: a retrospective chart review. Spinal Cord. 2019, 57:214-20. 10.1038\/s41393-018-0199-3","journal-title":"Spinal Cord"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2016.112","article-title":"In-hospital outcomes following single-dose radiation therapy in the treatment of heterotopic ossification of the hip following spinal cord injury-an analysis of 444 cases","volume":"55","author":"M\u00fcseler AC","year":"2017","unstructured":"M\u00fcseler AC, Grasm\u00fccke D, Jansen O, Aach M, Meindl R, Schildhauer TA, Citak M. In-hospital outcomes following single-dose radiation therapy in the treatment of heterotopic ossification of the hip following spinal cord injury-an analysis of 444 cases. Spinal Cord. 2017, 55:244-6. 10.1038\/sc.2016.112","journal-title":"Spinal Cord"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3928\/01477447-20090728-33","article-title":"Radiation therapy for preventing recurrence of neurogenic heterotopic ossification","volume":"32","author":"Cipriano C","year":"2009","unstructured":"Cipriano C, Pill SG, Rosenstock J, Keenan MA. Radiation therapy for preventing recurrence of neurogenic heterotopic ossification. Orthopedics. 2009, 32:10.3928\/01477447-20090728-33","journal-title":"Orthopedics"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/10790268.2000.11753507","article-title":"The effect of etidronate on late development of heterotopic ossification after spinal cord injury","volume":"23","author":"Banovac K","year":"2000","unstructured":"Banovac K. The effect of etidronate on late development of heterotopic ossification after spinal cord injury. J Spinal Cord Med. 2000, 23:40-4. 10.1080\/10790268.2000.11753507","journal-title":"J Spinal Cord Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-200401000-00013","article-title":"Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model","volume":"86","author":"Hannallah D","year":"2004","unstructured":"Hannallah D, Peng H, Young B, Usas A, Gearhart B, Huard J. Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am. 2004, 86:80-91. 10.2106\/00004623-200401000-00013","journal-title":"J Bone Joint Surg Am"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-200312000-00010","article-title":"In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification","volume":"85","author":"Glaser DL","year":"2003","unstructured":"Glaser DL, Economides AN, Wang L, et al.. In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am. 2003, 85:2332-42. 10.2106\/00004623-200312000-00010","journal-title":"J Bone Joint Surg Am"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008810","article-title":"Treatment of heterotopic ossification through remote ATP hydrolysis","volume":"6","author":"Peterson JR","year":"2014","unstructured":"Peterson JR, De La Rosa S, Eboda O, et al.. Treatment of heterotopic ossification through remote ATP hydrolysis. Sci Transl Med. 2014, 6:255ra132. 10.1126\/scitranslmed.3008810","journal-title":"Sci Transl Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1888","article-title":"BMP type I receptor inhibition reduces heterotopic [corrected] ossification","volume":"14","author":"Yu PB","year":"2008","unstructured":"Yu PB, Deng DY, Lai CS, et al.. BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med. 2008, 14:1363-9. 10.1038\/nm.1888","journal-title":"Nat Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2020.0162","article-title":"BMP ligand trap ALK3-Fc attenuates osteogenesis and heterotopic ossification in blast-related lower extremity trauma","volume":"30","author":"Strong AL","year":"2021","unstructured":"Strong AL, Spreadborough PJ, Dey D, et al.. BMP ligand trap ALK3-Fc attenuates osteogenesis and heterotopic ossification in blast-related lower extremity trauma. Stem Cells Dev. 2021, 30:91-105. 10.1089\/scd.2020.0162","journal-title":"Stem Cells Dev"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2820","article-title":"Palovarotene inhibits heterotopic ossification and maintains limb mobility and growth in mice with the human ACVR1(R206H) fibrodysplasia ossificans progressiva (FOP) mutation","volume":"31","author":"Chakkalakal SA","year":"2016","unstructured":"Chakkalakal SA, Uchibe K, Convente MR, et al.. Palovarotene inhibits heterotopic ossification and maintains limb mobility and growth in mice with the human ACVR1(R206H) fibrodysplasia ossificans progressiva (FOP) mutation. J Bone Miner Res. 2016, 31:1666-75. 10.1002\/jbmr.2820","journal-title":"J Bone Miner Res"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2334","article-title":"Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-\u03b3 agonists","volume":"17","author":"Shimono K","year":"2011","unstructured":"Shimono K, Tung WE, Macolino C, et al.. Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-\u03b3 agonists. Nat Med. 2011, 17:454-60. 10.1038\/nm.2334","journal-title":"Nat Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/jor.23747","article-title":"Palovarotene inhibits connective tissue progenitor cell proliferation in a rat model of combat-related heterotopic ossification","volume":"36","author":"Wheatley BM","year":"2018","unstructured":"Wheatley BM, Cilwa KE, Dey D, et al.. Palovarotene inhibits connective tissue progenitor cell proliferation in a rat model of combat-related heterotopic ossification. J Orthop Res. 2018, 36:1135-44. 10.1002\/jor.23747","journal-title":"J Orthop Res"},{"key":"ref43","unstructured":"An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva. (2017). https.\/\/clinicaltrials.gov\/ct2\/show\/NCT03312634."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glw090","article-title":"Rapamycin: an InhibiTOR of aging emerges from the soil of Easter Island","volume":"71","author":"Arriola Apelo SI","year":"2016","unstructured":"Arriola Apelo SI, Lamming DW. Rapamycin: an InhibiTOR of aging emerges from the soil of Easter Island. J Gerontol A Biol Sci Med Sci. 2016, 71:841-9. 10.1093\/gerona\/glw090","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-015-4240-y","article-title":"Early Characterization of Blast-related Heterotopic Ossification in a Rat Model","volume":"473","author":"Qureshi AT","year":"2015","unstructured":"Qureshi AT, Crump EK, Pavey GJ, Hope DN, Forsberg JA, Davis TA. Early Characterization of Blast-related Heterotopic Ossification in a Rat Model. Clin Orthop Relat Res. 2015, 473:2831-9. 10.1007\/s11999-015-4240-y","journal-title":"Clin Orthop Relat Res"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01406-8","article-title":"Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1","volume":"15","author":"Maekawa H","year":"2020","unstructured":"Maekawa H, Kawai S, Nishio M, et al.. Prophylactic treatment of rapamycin ameliorates naturally developing and episode -induced heterotopic ossification in mice expressing human mutant ACVR1. Orphanet J Rare Dis. 2020, 15:122. 10.1186\/s13023-020-01406-8","journal-title":"Orphanet J Rare Dis"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-016-0144-3","article-title":"Prevention of heterotopic ossification: an experimental study using a plasma expander in a murine model","volume":"16","author":"Zimmermann SM","year":"20164","unstructured":"Zimmermann SM, Schwitter LW, Scheyerer MJ, et al.. Prevention of heterotopic ossification: an experimental study using a plasma expander in a murine model. BMC Surg. 20164, 16:29. 10.1186\/s12893-016-0144-3","journal-title":"BMC Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/jor.20817","article-title":"Free radical scavengers versus methylprednisolone in the prevention of experimentally induced heterotopic ossification","volume":"27","author":"Vanden Bossche LC","year":"2009","unstructured":"Vanden Bossche LC, Van Maele G, Wojtowicz I, et al.. Free radical scavengers versus methylprednisolone in the prevention of experimentally induced heterotopic ossification. J Orthop Res. 2009, 27:748-51. 10.1002\/jor.20817","journal-title":"J Orthop Res"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.07.019","article-title":"Early clinical observations on the use of imatinib mesylate in FOP: a report of seven cases","volume":"109","author":"Kaplan FS","year":"2018","unstructured":"Kaplan FS, Andolina JR, Adamson PC, et al.. Early clinical observations on the use of imatinib mesylate in FOP: a report of seven cases. Bone. 2018, 109:276-80. 10.1016\/j.bone.2017.07.019","journal-title":"Bone"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s11420-013-9335-y","article-title":"Use of imatinib in the prevention of heterotopic ossification","volume":"9","author":"Werner CM","year":"2013","unstructured":"Werner CM, Zimmermann SM, W\u00fcrgler-Hauri CC, Lane JM, Wanner GA, Simmen HP. Use of imatinib in the prevention of heterotopic ossification. HSS J. 2013, 9:166-70. 10.1007\/s11420-013-9335-y","journal-title":"HSS J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/57397-new-strategies-in-neurogenic-heterotopic-ossification","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:59Z","timestamp":1707506879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/57397-new-strategies-in-neurogenic-heterotopic-ossification"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.14709","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,27]]}}}